benazeprilat

Known as: benezaprilat 
The active metabolite of benazepril, a carboxyl-containing angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. Once the… (More)
National Institutes of Health

Related topics

Related topics

12 relations
Amlodipine 10 MG / Benazepril hydrochloride 20 MG Oral CapsuleAmlodipine 10 MG / Benazepril hydrochloride 20 MG Oral Capsule [Lotrel]Amlodipine 10 MG / Benazepril hydrochloride 40 MG Oral CapsuleAmlodipine 10 MG / Benazepril hydrochloride 40 MG Oral Capsule [Lotrel]
(More)

Broader (4)

Angiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsBenzazepinesbenazepril

Narrower (1)

CGS 14831

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
Aliskiren, a novel, orally effective renin inhibitor, lowers blood pressure in marmosets and spontaneously hypertensive rats.
OBJECTIVES Aliskiren is a new renin inhibitor of a novel structural class that has recently been shown to be efficacious in… (More)
Is this relevant?
2003
2003
Pharmacokinetic/pharmacodynamic modelling of the disposition and effect of benazepril and benazeprilat in cats.
The disposition and effect of benazepril and its active metabolite, benazeprilat, were evaluated in cats using a pharmacokinetic… (More)
Is this relevant?
2000
2000
Benazeprilat disposition and effect in dogs revisited with a pharmacokinetic/pharmacodynamic modeling approach.
The pharmacokinetic disposition of benazeprilat, an angiotensin-converting enzyme (ACE) inhibitor (ACEI), was assessed with a… (More)
  • figure 1
  • figure 2
  • figure 4
  • table 1
  • figure 3
Is this relevant?
1999
1999
Plasma angiotensin converting enzyme activity and pharmacokinetics of benazepril and benazeprilat in cats after single and repeated oral administration of benazepril.HCl.
The plasma pharmacokinetics of benazepril and its active metabolite, benazeprilat, were determined in cats after oral… (More)
Is this relevant?
1997
1997
Pharmacokinetics of the angiotensin-converting-enzyme inhibitor, benazepril, and its active metabolite, benazeprilat, in dog.
1. The pharmacokinetics of the angiotensin-converting-enzyme (ACE) inhibitor benazepril were evaluated in eight healthy Beagle… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: I. Effects on left ventricular performance and neurohormonal…
BACKGROUND The goal of this study was to determine the effects of ACE inhibition (ACEI) alone, AT1 angiotensin (Ang) II receptor… (More)
Is this relevant?
1995
1995
Pharmacokinetics of the active metabolite of benazepril, benazeprilat, and inhibition of plasma angiotensin-converting enzyme activity after single and repeated administrations to dogs.
Plasma pharmacokinetic variables of benazeprilat, the active metabolite of the angiotensin-converting enzyme (ACE) inhibitor… (More)
Is this relevant?
1993
1993
Hemodynamic effects of amlodipine and benazeprilat in spontaneously hypertensive rats.
We wished to assess the hemodynamic effects of administration of the combination of the calcium channel blocking agent amlodipine… (More)
Is this relevant?
Highly Cited
1991
Highly Cited
1991
Angiotensin-converting enzyme inhibitor versus angiotensin II, AT1 receptor antagonist. Effects on smooth muscle cell migration and proliferation after balloon catheter injury.
The angiotensin-converting enzyme (ACE) inhibitor, benazeprilat and the angiotensin II (Ang II), AT1-specific receptor antagonist… (More)
Is this relevant?
Highly Cited
1990
Highly Cited
1990
Determinants of angiotensin II generation during converting enzyme inhibition.
The reaction of the renin-angiotensin system to acute angiotensin converting enzyme inhibition was investigated in a single-blind… (More)
  • table 1
  • figure 1
  • table 2
  • figure 3
  • figure 2
Is this relevant?